Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER_GOV × Anemia × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

INDUSTRY 32 OTHER 23 NIH 4 OTHER_GOV 1 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Classical hematology 1

Conditions

Breast Neoplasms 48 Carcinoma, Non-Small-Cell Lung 29 Stomach Neoplasms 26 Colorectal Neoplasms 19 Small Cell Lung Carcinoma 17 Lung Neoplasms 16 Rectal Neoplasms 14 Neoplasm Metastasis 14 Pancreatic Neoplasms 12 Neoplasms 12 Esophageal Neoplasms 11 Ovarian Neoplasms 10 Nasopharyngeal Carcinoma 10 Uterine Cervical Neoplasms 9 Recurrence 9 Leukemia, Myeloid, Acute 9 Carcinoma, Hepatocellular 9 Melanoma 7 Lymphoma, Non-Hodgkin 7 Triple Negative Breast Neoplasms 6 Hodgkin Disease 6 Head and Neck Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Colonic Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms, Germ Cell and Embryonal 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma 5 Cholangiocarcinoma 5 Adenocarcinoma of Lung 5

Interventions

ferric carboxymaltose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02628860 2020-04-28

FCM

National Cancer Center, Korea

Phase 2 Completed

Classical hematologyGastrointestinal

Anemia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡